ExFlyBoy5
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
An acquaintance of mine was telling about an FTC action in regards to a proposed merger. While the FTC action isn't very exciting, what IS exciting is that there is one company that is on the cusp of getting FDA approval for an advanced method of detecting cancer from dead cells that have been "shed" and can be detected by advanced DNA screening. I won't get into the specifics, but basically...a simple blood draw (or as they call it, a liquid biopsy) can detect up to 50 types of cancer and can often tell where it is. This is an amazing discovery and could be something that is a real game changer in cancer detection.
Currently, it's a private company (big investors include Jeff Bezos and Bill Gates).
It appears that you can get a test through your doctor (don't know if/what restrictions there might be) and it costs in the neighborhood of $950-1000 for the test.
There are other companies working on a similar test, but they seem to be in the running for the first FDA approval.
I am debating on asking my MD about this test *before* it gets approval. If/when it gets approval, I would guess it will be a very popular test and demand could make getting it in a timely manner questionable.
A couple of articles for further reading:
https://en.wikipedia.org/wiki/GRAIL_(company)
https://grail.com/our-products
https://www.galleri.com/uploads/downloads/Galleri-Cancers-Detected-Chart_0323.pdf
Currently, it's a private company (big investors include Jeff Bezos and Bill Gates).
It appears that you can get a test through your doctor (don't know if/what restrictions there might be) and it costs in the neighborhood of $950-1000 for the test.
There are other companies working on a similar test, but they seem to be in the running for the first FDA approval.
I am debating on asking my MD about this test *before* it gets approval. If/when it gets approval, I would guess it will be a very popular test and demand could make getting it in a timely manner questionable.
A couple of articles for further reading:
https://en.wikipedia.org/wiki/GRAIL_(company)
https://grail.com/our-products
https://www.galleri.com/uploads/downloads/Galleri-Cancers-Detected-Chart_0323.pdf
Their liquid biopsy, still undergoing research as of November 2020 and called the 'Galleri test', detects fragments of DNA in a blood sample via next-generation sequencing, which identifies DNA methylation, distinct patterns of which are associated with particular cancers, potentially allowing for the early detection of cancer and providing information of the origin of the cancer. It is one of three multicancer screening tests under investigation; the other two being the CancerSEEK assay and the PanSeer assay.